Geron Corp. buy BiotechBee
Start price
04.01.23
/
60%
€2.50
Target price
31.12.25
€6.00
Performance (%)
38.38%
End price
04.01.23
€3.46
Summary
This prediction ended on 04.01.23 with a price of €3.46. The BUY prediction by BiotechBee for Geron Corp. saw massive gains of 38.38%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Geron Corp. | -5.174% | -5.174% | 69.825% |
iShares Core DAX® | 3.054% | 0.066% | 16.889% |
iShares Nasdaq 100 | 4.389% | -2.130% | 31.443% |
iShares Nikkei 225® | 5.386% | -0.624% | 16.546% |
iShares S&P 500 | 2.955% | -0.948% | 26.821% |
According to BiotechBee what are the pros and cons of Geron Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Geron Corp. diskutieren
Buy mit Kursziel 6,0
In the thread Trading Geron Corp.
Buy beendet
Stopped prediction by BiotechBee for Geron Corp.
Geron Corp.
Start price
Target price
Perf. (%)
€2.10
03.03.24
03.03.24
€3.70
31.08.26
31.08.26
108.05%
11.08.24
11.08.24
Could be very worthwhile Investment >20% year
Geron Corp.
Start price
Target price
Perf. (%)
€2.88
24.06.23
24.06.23
€4.00
30.04.26
30.04.26
-27.18%
03.03.24
03.03.24
Could be very worthwhile Investment >20% year